StockTipsArenaBeta

BUY Mankind Pharma Limited — Laxmikant Shukla, YES Securities

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byLaxmikant Shukla, YES SecuritiesHorizon: NA (inferred Swing (≤2wk))15 Jul 2026via ET Now

Entry₹2,550Inferred
Target₹2,700
Total upside +5.88% (call closed)
Stop loss₹2,500-1.96% risk
Exit₹2,50017 Jul 2026, 11:30 am
Stop-loss hit-1.96%
Follow Laxmikant Shukla for new calls(29% target hit, 113 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Jul 2026
3 supporting4 neutral0 opposing
Supports the BUY call (3)

Mankind Pharma completes sale of Broadway Hospitality stake for ₹49 crore

NewsGoogle News·27 Jul · today

(opens in new tab)

4 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·28 Jul · today

5 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·28 Jul · today

Neutral / worth noting (4)

Mankind Pharma Limited's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly-owned subsidiary in Netherlands for R&D inve

NSE · Acquisition·11 Jul · 2w ago

(opens in new tab)

Mankind Pharma Ltd's Board approved the incorporation of a wholly owned subsidiary in the Netherlands.

BSE · Company Update·11 Jul · 2w ago

(opens in new tab)

Mankind Pharma Limited's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly owned subsidiary in Netherlands for R&D inve

NSE · Outcome of Board Meeting·11 Jul · 2w ago

(opens in new tab)

Mankind Pharma's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly-owned subsidiary in Netherlands for R&D investments.

BSE · Others·11 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Laxmikant Shukla, YES Securities

Every call and its outcome